ResearchMoz

Mobile Phone Insurance Revenue by Country & Region Database: 2013 - 2018

Signals and Systems Telecom
Published Date » 2013-07-13
No. Of Pages » N/A

Driven by the growing penetration of mid-range and high-end Smartphones, the mobile phone insurance industry is increasingly gaining momentum. As device vendors intensely compete by launching new and unique Smartphone models, insurance companies are heavily capitalizing on device specific insurance plans. With global revenues of over $30 Billion in 2013, the industry is set to grow at a CAGR of 17 % over the next five years. By 2018, it is estimated that the industry would be worth $61 Billion. The “Mobile Phone Insurance Revenue by Country & Region Database: 2013 – 2018” tracks historical revenues and yearly forecasts for the global mobile insurance industry at both country and regional levels.

This Excel database covers the following:

Mobile phone Insurance revenue & growth rate (CAGR) by region for the following 7 categories:

  • Africa
  • Asia Pacific
  • Eastern Europe
  • Latin & Central America
  • Middle East
  • North America
  • Western Europe

Mobile phone insurance revenue & growth rate (CAGR) by country for the following 54 countries:

  • Argentina
  • Australia
  • Austria
  • Belgium
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Croatia
  • Czech Republic
  • Egypt
  • France
  • Germany
  • Greece
  • Hong Kong
  • Hungary
  • India
  • Indonesia
  • Iran
  • Ireland
  • Israel
  • Italy
  • Japan
  • Jordan
  • Kenya
  • Korea
  • Lithuania
  • Malaysia
  • Mexico
  • Netherlands
  • New Zealand
  • Nigeria
  • Pakistan
  • Philippines
  • Poland
  • Portugal
  • Romania
  • Russia
  • Saudi Arabia
  • Singapore
  • Slovak Republic
  • South Africa
  • Spain
  • Sweden
  • Taiwan
  • Thailand
  • Turkey
  • UAE
  • Uganda
  • UK
  • Ukraine
  • USA

Additional Information

Countires Covered

  • Argentina
  • Australia
  • Austria
  • Belgium
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Croatia
  • Czech Republic
  • Egypt
  • France
  • Germany
  • Greece
  • Hong Kong
  • Hungary
  • India
  • Indonesia
  • Iran
  • Ireland
  • Israel
  • Italy
  • Japan
  • Jordan
  • Kenya
  • Korea
  • Lithuania
  • Malaysia
  • Mexico
  • Netherlands
  • New Zealand
  • Nigeria
  • Pakistan
  • Philippines
  • Poland
  • Portugal
  • Romania
  • Russia
  • Saudi Arabia
  • Singapore
  • Slovak Republic
  • South Africa
  • Spain
  • Sweden
  • Taiwan
  • Thailand
  • Turkey
  • UAE
  • Uganda
  • UK
  • Ukraine
  • USA 
TABLE OF CONTENT

1 Mobile Phone Insurance Revenue & CAGR (%) in Africa
1.1 Egypt
1.2 Kenya
1.3 Nigeria
1.4 Rest of Africa
1.5 South Africa
1.6 Uganda
1.7 Africa Summary/Total

2 Mobile Phone Insurance Revenue & CAGR (%) in Asia Pacific
2.1 Australia
2.2 China
2.3 Hong Kong
2.4 India
2.5 Indonesia
2.6 Japan
2.7 Korea
2.8 Malaysia
2.9 New Zealand
2.10 Pakistan
2.11 Philippines
2.12 Rest of Asia Pacific
2.13 Singapore
2.14 Taiwan
2.15 Thailand
2.16 Asia Pacific Summary/Total

3 Mobile Phone Insurance Revenue & CAGR (%) in Eastern Europe
3.1 Bulgaria
3.2 Croatia
3.3 Czech Republic
3.4 Hungary
3.5 Lithuania
3.6 Poland
3.7 Rest of Eastern Europe
3.8 Romania
3.9 Russia
3.10 Slovak Republic
3.11 Ukraine
3.12 Eastern Europe Summary/Total

4 Mobile Phone Insurance Revenue & CAGR (%) in Latin & Central America
4.1 Argentina
4.2 Brazil
4.3 Chile
4.4 Colombia
4.5 Mexico
4.6 Rest of Latin & Central America
4.7 Latin & Central America Summary/Total

5 Mobile Phone Insurance Revenue & CAGR (%) in the Middle East
5.1 Iran
5.2 Jordan
5.3 Rest of the Middle East
5.4 Saudi Arabia
5.5 UAE
5.6 Israel
5.7 Middle East Summary/Total

6 Mobile Phone Insurance Revenue & CAGR (%) in North America
6.1 Canada
6.2 USA
6.3 North America Summary/Total

7 Mobile Phone Insurance Revenue & CAGR (%) in Western Europe
7.1 Austria
7.2 Belgium
7.3 France
7.4 Germany
7.5 Greece
7.6 Ireland
7.7 Italy
7.8 Netherlands
7.9 Portugal
7.10 Rest of Western Europe
7.11 Spain
7.12 Sweden
7.13 Turkey
7.14 UK
7.15 Western Europe Summary/Total

8 Worldwide Mobile Phone Insurance Revenue & CAGR (%) Summary/Total

List of Tables

NA

List of Figures

NA

Upcoming Reports:

Hemoglobin A1c Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Blood glucose testing at regular intervals is very crucial for diabetic patients, in order to keep a track of fluctuating glucose levels in the blood. The crucial aim of diabetes treatment is to ensure normal levels of blood glucose. Hemoglobin A1c (Hb A1c) is a lab test that gives an idea about average levels of blood sugar for a period of around three months. The test results give an idea about the efficacy of diabetes treatment plans. It provides insights on the following parameters: Success of the designed diabetes treatment plan. Accuracy of test results...
Merchant-Paid Rewards Market: Industry Analysis, Market Size, Share, Trends, Growth And Forecast, 2011 - 2018
By - Transparency Market Research
Debit card users are increasing in number as compared to credit card users. Use of debit card allows the consumers to save money for future use as they know how much money they have and how much money they have to spend. This trend leads to the growth of merchant paid reward programs. Credit cards do not give customers this privilege as they pay later for whatever they have purchased. Merchant-paid programs persuade customers to use their debit cards rather than credit cards or paper coupons. Merchant paid programs are gaining popularity in the market as it offers...
Anti-Tumor Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Tumor is also termed as neoplasm and it is caused by an abnormal proliferation of tissues. This abnormal proliferation can be due to genetic mutations. Tumors can be subcategorized as benign and malignant. Benign is not destructive however, possess a potential to turn into a malignant tumor...  It has been observed that cancer is second leading cause of deaths in Europe and North America. To treat these tumor growth, anti tumor drugs are considered as of one of the key therapy which has been accepted worldwide. Various drugs are used to treat tumors which includes...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Top End Stereo Systems Maker Harman Targets Chinese Auto Market
Apr 22, 2014  
Harman, the U.S.-based audio company that is best known as the provider of automobile stereos for top-end car models such as Mercedes-Benz, BMW and Ferrari, has said that it has signed agreements with two leading Chinese automakers—Chang’An and Geely. The company, that is associated with premium infotainment systems for leading auto makers, said that these new contracts...
Scientists Identify Cure for Dengue
Apr 18, 2014  
In a breakthrough discovery that can change the way dengue is treated, scientists have identified a drug target for the deadly dengue viruses. This discovery may help pave the way for discovery of vaccines that can cure this condition that affects nearly 390 million people throughout the world each year.  Scientists have used a new technique for this discovery to show that a region...
India is Facing a Cancer Crisis
Apr 15, 2014  
India is currently facing a cancer crisis – reports a recent research carried out at the King’s college London, in collaboration with the Tata Memorial Cancer Centre, Mumbai.  The reasons estimated for this crisis comprise of increasing rates of smoking, unequal access to proper treatment and belated diagnosis.  Every year, India witnesses around one...
Microparticle Tags to Check Counterfeit Goods Invented
Apr 14, 2014  
Researchers from the Massachusetts Institute of Technology have invented a new set of microparticles that can easily be read by smartphones and establish the authenticity of currency, electronic items and luxury goods.  This strategy is among those countless measures taken by big brands and companies to label their legitimate products in order to stop illegal copies of the...
USFDA Approves Lupins Generic Diabetic Drug
Apr 10, 2014  
The United States Food and Drugs Administration (USFDA) has finally approved Lupin Pharmaceuticals Inc (LPI), the American subsidiary of Indian drug manufacturers Lupin Ltd, to sell Pioglitazone Tablets in the U.S market. The approval has been granted first for fiscal 2015.  Pioglitazone is a generic medicine used for managing diabetes and is a version of Actos tablets...